Elvira A. Imelbaeva

Elvira A. Imelbaeva

Auto-generated profile, based on publicly available information

Elvira A. Imelbaeva

Bashkir State Medical University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2023 in Terapevt (General Physician)
Verified
Journal Article
Closed access
EIE. A. E. A. Imelbaeva
E. A. E. A. Imelbaeva
AGA. Zh. Gilmanov
A. Zh. Gilmanov
LSL. M. Saptarova
L. M. Saptarova

22 September 2023 in Terapevt (General Physician)
Verified
Journal Article
Closed access
EIE. A. Imelbaeva
E. A. Imelbaeva
TLT. M. Lukyanova
T. M. Lukyanova
AGA. Zh. Gilmanov
A. Zh. Gilmanov
RIR. R. Ismagilov
R. R. Ismagilov
SKState Budgetary Healthcare Institution «Republican Clinical Hospital Named After G. G. Kuvatov»
State Budgetary Healthcare Institution «Republican Clinical Hospital Named After G. G. Kuvatov»

1 January 2023 in Современные проблемы науки и образования (Modern Problems of Science and Education)
Verified
Journal Article
Open access
LSL.M. Saptarova
L.M. Saptarova
GBG.A. Bayburina
G.A. Bayburina
EBE.R. Bikmetova
E.R. Bikmetova
EIE.A. Imelbaeva
E.A. Imelbaeva
DBD.E. Bayburina
D.E. Bayburina
SGS.N. Galimov
S.N. Galimov

1 January 2022 in Medical Science And Education Of Ural
Verified
Journal Article
Closed access
LSLiliyana M. Saptarova
Liliyana M. Saptarova
EIElvira A. Imelbaeva
Elvira A. Imelbaeva
GSGulnara F. Shakirova
Gulnara F. Shakirova
ATAliya V. Tukhbatova
Aliya V. Tukhbatova
DBDina E. Bayburina
Dina E. Bayburina
SGShamil N. Galimov
Shamil N. Galimov

22 September 2023 in Terapevt (General Physician)
Verified
Journal Article
Closed access
EIE.A. Imelbaeva
E.A. Imelbaeva
BUBashkir State Medical University"
Bashkir State Medical University"
UFUfa
Ufa
AGA.Zh. Gilmanov
A.Zh. Gilmanov
LSL.M. Saptarova
L.M. Saptarova
The article presents the results of a study of phagocytosis parameters and levels of antibodies to SARS‑CoV‑2 in the blood of 26 doctors: 14 pediatricians and 12 residents of the clinical laboratory diagnostics. The data obtained revealed a reduced number of eosinophils and lymphocytes in the blood and higher values of phagocytic activity and levels of antibodies to SARS‑CoV‑2 in the pediatricians compared to the residents, which indicates a decrease in the reactivity of their body and a greater tension of natural protection factors. No significant correlation between antibody levels and phagocytosis parameters was found, which may indicate their autonomous response to a viral infection.

2 December 2022 in Kazan medical journal
Verified
Journal Article
Closed access
PDF file
LSLiliyana M. Saptarova
Liliyana M. Saptarova
EIElvira A. Imelbaeva
Elvira A. Imelbaeva
ATAliya V. Tukhbatova
Aliya V. Tukhbatova
SGShamil N. Galimov
Shamil N. Galimov
NMNatalia A. Mufazalova
Natalia A. Mufazalova
ТВТухбатова Алия Валерьевна
Тухбатова Алия Валерьевна
Background. Cytokine homeostasis is an important factor characterizing the general condition and adaptive capabilities of the body of patients with malignant neoplasms. However, the role of various growth factors and their significance in the development and enhancement of malignant growth in breast cancer remain poorly understood. Aim. To evaluate the levels of cytokines - tumor necrosis factor , interleukins-4, -6, -8 and -10 in the blood serum of patients with different stages of breast cancer in comparison with healthy volunteers. Material and methods. The study was conducted in 65 patients aged 25 to 67 years (mean age 44.5 [40.056.5] years). Two groups were distinguished: the first with stage 12, the second with stage 34 of breast cancer. The comparison group consisted of 15 apparently healthy women without cancer, aged 29 to 66 years (mean age 51.0 [39.061.0] years). Blood levels of tumor necrosis factor , interleukins-4, -6, -8 and -10 were studied by enzyme immunoassay. The obtained data were processed using the methods of variation statistics, the Statistica 10.0 software package. The significance of differences was assessed by calculating the median and interquartile interval, analysis of variance was performed using the KruskalWallis H-test, and Dan's Q-test was used for multiple comparisons. The critical significance level p for statistical tests was taken equal to 0.05. Results. In the group of patients with stage 12 breast cancer, an increase in the blood levels of all studied cytokines was revealed in comparison with the group of healthy women: interleukin-6 (p=0.00719), interleukin-8 (p=0.00259), tumor necrosis factor (p=0.00014), interleukin-4 (p1=0.0133), interleukin-10 (p1 0.00001). In the group of patients with stage 34 breast cancer, an increase in blood levels was characteristic of all studied cytokines: interleukin-8 (p=0.00009), tumor necrosis factor (p=0.000004), interleukin-4 (p 0.00001), interleukin-10 (p 0.00001), except for interleukin-6 (p=0.15608). The established patterns in changes in the content of cytokines in the blood of patients with breast cancer at different stages of development can serve as the basis for developing approaches to the diagnosis and treatment of the disease. Conclusion. In patients with breast cancer, the levels of tumor necrosis factor , interleukins-4, -6, -8, -10 (p 0.05) are higher than in healthy women.